Trial Profile
Phase IIa trial of AVN 211 in patients with schizophrenia stabilised on atypical antipsychotic therapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2013
Price :
$35
*
At a glance
- Drugs AVN 211 (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- 15 Jul 2013 Positive top-line results published in CNS Spectrums, according to an Avineuro Pharmaceuticals media release.
- 24 Feb 2011 Top-line data reported in a Avineuro Pharmaceuticals media release.
- 10 Feb 2010 New trial record